Skip to main content
. Author manuscript; available in PMC: 2024 Feb 28.
Published in final edited form as: Chembiochem. 2018 Sep 5;19(18):1907–1912. doi: 10.1002/cbic.201800173

Table 1.

Comparing irreversible analogues of 1–10 against GACKIX N627C.[a]

graphic file with name nihms-1009900-t0004.jpg
Compound Dose-response Fold inhibition
DR50 [mM] MLL pKID

1–10a graphic file with name nihms-1009900-t0005.jpg 25 12±1 0.9±0.1
1–10b graphic file with name nihms-1009900-t0006.jpg 150 13±1 1.4±0.2
1–10c graphic file with name nihms-1009900-t0007.jpg 6.8 17±2 1.5±0.2
1–d graphic file with name nihms-1009900-t0008.jpg 4.6 17±2 0.65±0.08
1–e graphic file with name nihms-1009900-t0009.jpg >500 14±2 0.88±0.09
1–f graphic file with name nihms-1009900-t0010.jpg >500 5.9±0.6 0.66±0.07
[a]

The DR50 values were assessed by measuring the extent of GACKIX N627C labeled by means of Q-TOF LC-MS at various concentrations of compound. The fold inhibition values were obtained by comparing the dissociation constants (KD) for the unlabeled (DMSO) KIX N627C construct with the KD values for the labeled KIX N627C–1–10 alkylator complex for both the MLL and pKID tracers. The KD values were measured from fluorescence polarization (FP) experiments that were performed in triplicate and errors reflect the standard deviation (SD) error.